The Pep3 treatment significantly restricted tumor development in the esophageal tissues (Fig. 7G), which was consistent with the tumor inhibition shown in Fig. 7D. In contrast, the control group had an elevated expression of Ki67. The gene discussed is VPS18; the disease is neoplasm.